Lipoprotein-bound LPS induces cytokine tolerance in hepatocytes

Journal of Endotoxin Research

Volumn 9, Issue 1, 2003, Pages 45-50

  Harris, Hobart W ^a   Kasravi, F Behzad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHYLOMICRON; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN; NITRIC OXIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACUTE PHASE RESPONSE; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; HYPERLIPOPROTEINEMIA; IMMUNE RESPONSE; LIPID BLOOD LEVEL; LIVER CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; CHYLOMICRONS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG TOLERANCE; HEPATOCYTES; HUMANS; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); RODENTIA;

EID: 0037226465     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103125001333     Document Type: Conference Paper

References (21)

1. Banerjee S, Bhaduri J. Serum protein-bound carbohydrates and lipids in cholera. Proc Exp Biol Med 1959; 101: 340-341.
2. Gallin JI, Kaye D, O'Leary WM. Serum lipids in infection. N Engl J Med 1969; 281: 1081-1086.
3. Ulevitch RJ, Johnston AR, Weinstein DB. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 1979; 64: 1516-1524.
4. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696-702.
5. Harris HW, Rockey DC, Young DM, Welch WJ. Diet-induced protection against lipopolysaccharide includes increased hepatic NO production. J Surg Res 1999; 82: 339-345.
6. Read TE, Grunfeld C, Kumwenda Z et al. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery 1995; 117: 62-67.
7. Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 1997; 99: 2438-2445.
8. Harris HW, Rockey DC, Chau P. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 1998; 27: 1341-1348.
9. Van Oosten M, Rensen PC, Van Amersfoort ES et al. Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat Gram-negative sepsis. J Biol Chem 2001; 276: 8820-8824.
10. de Bont N, Netea MG, Demacker PN et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999; 40: 680-685.
11. Kumwenda Z, Welch W, Harris H. Chylomicron-bound endotoxin inhibits hepatocellular nitric oxide production by inhibiting nuclear factor-κB activation in rats. Surg Forum 1998; 49: 8-9.
12. Kumwenda ZL, Wong CB, Johnson JA, Gosnell JE, Welch WJ, Harris HW. Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock 2002; 18: 182-188.
13. Harris HW, Gosnell JE, Kumwenda ZL. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000; 6: 421-430.
14. Chappell DA, Medh JD. Receptor-mediated mechanisms of lipoprotein remnant catabolism. Prog Lipid Res 1998; 37: 393-422.
15. Redgrave TG, Maranhao RC. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 1985; 835: 104-112.
16. Zeng BJ, Mortimer BC, Martins IJ, Seydel U, Redgrave TG. Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. J Lipid Res 1998; 39: 845-860.
17. Kasravi F, Welch WJ, Peters-Lideu C, Weisgraber K, Harris HW. Induction of cytokine tolerance in rodent hepatocytes by chylomicron-bound LPS is LDL receptor dependent. Shock 2003; In Press
18. Read TE, Harris HW, Grunfeld C, Feingold KR, Kane JP, Rapp JH. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 1993; 14 (Suppl K): 125-129.
19. Roselaar SE, Daugherty A. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 1998; 39: 1740-1743.
20. de Bont N, Netea MG, Demacker PN, Kullberg BJ, van der Meer JW, Stalenhoef AF. Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest 2000; 30: 818-822.
21. Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537.